Chronic Pain: From Prevention to Therapeutic Strategies—Second Edition

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 616

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
2. Institute for Research and Innovation in Health—I3S, University of Porto, 4200-135 Porto, Portugal
Interests: mechanisms of pain modulation

E-Mail Website
Guest Editor
1. Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
2. Institute for Research and Innovation in Health—I3S, University of Porto, 4200-135 Porto, Portugal
Interests: pain; biomarkers; quantitative sensory tests; cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pain is a very complex and fascinating subject with three main components: physical, cognitive and emotional. These components are intrinsically connected, and their mutual influences may account for the individuality and subjectivity of pain responses.

Acute pain is usually an alert mechanism that protects the body from further tissue injury. On the other hand, chronic pain is considered a disease that is usually difficult to manage. Many chronic pain patients never achieve satisfactory pain relief. Despite the extensive investigation of pain treatment, there is still the need for research, namely in chronic pain prevention by establishing the mechanisms involved in the earlier phases of the disease. This may pass from the experimental setting to the clinical. For example, and with regard to the latter, proper postoperative pain prevention and adequate management starting in the preoperative period is imperative, and cancer management may lead to chronic pain, which is not usually prevented. Furthermore, a huge emphasis has been placed on the physical component of pain, whereas cognitive and emotional components of the pain experience are understudied, namely due to the challenges of animal pain models.

This Special Issue aims to provide the best up-to-date information on research related to prevention of chronic pain. Studies may include experimental and comprehensive reviews in this field and are expected to include the challenges related to animal research, genetic tests, novel biomarkers, predictive sensory testing, cognitive behavioral approaches for emotional component of pain, and individualization of pain patients.

Dr. Isaura Tavares
Dr. Daniel Humberto Pozza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pain pathophysiology
  • pain prevention
  • predictive sensory testing
  • pre- and postoperative chronic pain
  • new biomarkers in pain
  • pain management and novel treatments
  • preemptive analgesia
  • inflammatory pain

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

7 pages, 393 KiB  
Communication
Rikkosan’s Short-Term Analgesic Effect on Burning Mouth Syndrome: A Single-Arm Cohort Study
by Tatsuki Itagaki, Keisuke Nakamura, Tougo Tanabe, Takumi Shimura, Yu Nakai, Ken-ichiro Sakata, Jun Sato and Yoshimasa Kitagawa
Biomedicines 2024, 12(5), 1013; https://doi.org/10.3390/biomedicines12051013 - 4 May 2024
Viewed by 384
Abstract
Burning mouth syndrome (BMS) is a chronic oral pain disorder. There is a theory that BMS is a form of nociplastic pain. A standard treatment for BMS has not yet been established. Kampo medicine is a traditional oriental medicine. The purpose of this [...] Read more.
Burning mouth syndrome (BMS) is a chronic oral pain disorder. There is a theory that BMS is a form of nociplastic pain. A standard treatment for BMS has not yet been established. Kampo medicine is a traditional oriental medicine. The purpose of this study is to evaluate the effectiveness of Rikkosan—a traditional Japanese herbal medicine (Kampo)—in the treatment of BMS. A single-center retrospective study was conducted on 20 patients who were diagnosed with BMS and treated with Rikkosan alone (total daily dose; 7.5 g) three times daily for approximately 4 weeks (29.5 ± 6.5 days). Rikkosan was dissolved in hot water and taken internally. They had an average age of 63 years, and 90% were being treated for other illnesses, but their medication status was the same during this study period, except for Rikkosan. No adverse events were observed in patients. Numerical rating scale (NRS) or visual analog scale (VAS)/10 scores decreased significantly between the time of the initiation of Rikkosan and one month after (−2.1 ± 1.2, p < 0.05). Rikkosan has a short-term effect of reducing NRS by two levels in BMS patients. Full article
Show Figures

Figure 1

Back to TopTop